Literature DB >> 20646913

An investigation of 3 neurocognitive subtypes in schizophrenia.

Narmeen Ammari1, R Walter Heinrichs, Ashley A Miles.   

Abstract

The purpose of this investigation was to identify patients with cognitively impaired, cognitively normal and verbal memory-impaired subtypes of schizophrenia and to examine their clinical and functional validity as distinct forms of the disorder. These subtypes occurred in 73 of 154 patients meeting DSM-IV criteria for schizophrenia or schizoaffective disorder. A control group comprised of 18 healthy participants was also analyzed. Patient subtype and healthy groups were compared on adjunct cognitive as well as clinical and functional measures. The data support the cognitive validity and differentiation of these subtypes, with evidence that the generalized cognitive normality/impairment distinction associates with important aspects of symptom severity and functional outcome. Support for the clinical and functional validity of the verbal memory subtype was more equivocal. Overall, cognitively-based subtyping merits additional attention in efforts to organize the heterogeneity of the schizophrenia syndrome. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20646913     DOI: 10.1016/j.schres.2010.04.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment.

Authors:  Elsa Gilbert; Chantal Mérette; Valérie Jomphe; Claudia Emond; Nancie Rouleau; Roch-Hugo Bouchard; Marc-André Roy; Thomas Paccalet; Michel Maziade
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-31       Impact factor: 5.270

2.  Domain-specific cognitive course in schizophrenia: Group- and individual-level changes over 10 years.

Authors:  Camilla Bärthel Flaaten; Ingrid Melle; Thomas Bjella; Magnus Johan Engen; Gina Åsbø; Kristin Fjelnseth Wold; Line Widing; Erlend Gardsjord; Linn-Sofie Sæther; Merete Glenne Øie; Siv Hege Lyngstad; Beathe Haatveit; Carmen Simonsen; Torill Ueland
Journal:  Schizophr Res Cogn       Date:  2022-06-22

Review 3.  The global cognitive impairment in schizophrenia: consistent over decades and around the world.

Authors:  Jonathan Schaefer; Evan Giangrande; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2013-08-02       Impact factor: 4.939

4.  Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial.

Authors:  Yukihiko Shirayama; Michio Takahashi; Masatoshi Suzuki; Yoshiaki Tsuruoka; Koichi Sato
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-12-26       Impact factor: 2.582

5.  Multivariate neuroanatomical classification of cognitive subtypes in schizophrenia: a support vector machine learning approach.

Authors:  Ian C Gould; Alana M Shepherd; Kristin R Laurens; Murray J Cairns; Vaughan J Carr; Melissa J Green
Journal:  Neuroimage Clin       Date:  2014-09-18       Impact factor: 4.881

6.  Interactive effects of polygenic risk and cognitive subtype on brain morphology in schizophrenia spectrum and bipolar disorders.

Authors:  Yann Quidé; Oliver J Watkeys; Leah Girshkin; Manreena Kaur; Vaughan J Carr; Murray J Cairns; Melissa J Green
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-06       Impact factor: 5.760

7.  Identifying and revealing different brain neural activities of cognitive subtypes in early course schizophrenia.

Authors:  Tiannan Shao; Weiyan Wang; Gangrui Hei; Ye Yang; Yujun Long; Xiaoyi Wang; Jingmei Xiao; Yuyan Huang; Xueqin Song; Xijia Xu; Shuzhan Gao; Jing Huang; Ying Wang; Jingping Zhao; Renrong Wu
Journal:  Front Mol Neurosci       Date:  2022-10-03       Impact factor: 6.261

8.  The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes.

Authors:  Ruth Wells; Vaidy Swaminathan; Suresh Sundram; Danielle Weinberg; Jason Bruggemann; Isabella Jacomb; Vanessa Cropley; Rhoshel Lenroot; Avril M Pereira; Andrew Zalesky; Chad Bousman; Christos Pantelis; Cynthia Shannon Weickert; Thomas W Weickert
Journal:  NPJ Schizophr       Date:  2015-11-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.